Oncology/Hematology
Prostate Cancer
More in Prostate Cancer
Tests do not appear to consistently influence risk classification or treatment decisions
Jan 20, 2025
25 drugs chosen so far comprise about a third of Medicare Part D spending on prescription drugs
Jan 17, 2025
Distant metastases identified in 46% of "negative" cases, including polymetastatic disease in 24%
Jan 06, 2025
1.00
CME Credits